Methotrexate: The Enduring Pillar of RA Treatment

Methotrexate is projected to remain a central treatment for rheumatoid arthritis in the next decade. Data collected from over 400 rheumatologists across 64 countries highlights strong adherence to folate dosing guidelines. In the U.S., 97% of rheumatologists administer a milligram of folate per day alongside methotrexate, while globally, this practice is followed by about 50%. This indicates a significant consensus on the initial therapy for rheumatoid arthritis, reflecting the drug's longstanding efficacy and continuing relevance in treatment strategies.